Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/78268
Citations | ||
Scopus | Web of ScienceĀ® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Anandarajan, T. | - |
dc.contributor.author | Tibrewal, P. | - |
dc.contributor.author | Dhillon, R. | - |
dc.contributor.author | Bastiampillai, T. | - |
dc.date.issued | 2012 | - |
dc.identifier.citation | Australian and New Zealand Journal of Psychiatry, 2012; 46(6):792-793 | - |
dc.identifier.issn | 0004-8674 | - |
dc.identifier.issn | 1440-1614 | - |
dc.identifier.uri | http://hdl.handle.net/2440/78268 | - |
dc.description | Letter to the Editor | - |
dc.description.statementofresponsibility | Tharani Anandarajan, Prashant Tibrewal, Rohan Dhillon and Tarun Bastiampilla | - |
dc.language.iso | en | - |
dc.publisher | Blackwell Publishing Asia | - |
dc.rights | Copyright status unknown | - |
dc.source.uri | http://dx.doi.org/10.1177/0004867412445171 | - |
dc.subject | Humans | - |
dc.subject | Hyperprolactinemia | - |
dc.subject | Piperazines | - |
dc.subject | Risperidone | - |
dc.subject | Quinolones | - |
dc.subject | Antipsychotic Agents | - |
dc.subject | Delayed-Action Preparations | - |
dc.subject | Drug Monitoring | - |
dc.subject | Treatment Outcome | - |
dc.subject | Schizophrenia | - |
dc.subject | Adult | - |
dc.subject | Female | - |
dc.subject | Medication Therapy Management | - |
dc.subject | Drug Substitution | - |
dc.subject | Pharmacovigilance | - |
dc.subject | Aripiprazole | - |
dc.title | Hyperprolactinaemia on depot risperidone treated with aripiprazole | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1177/0004867412445171 | - |
pubs.publication-status | Published | - |
Appears in Collections: | Aurora harvest 4 Psychiatry publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.